[Changes in enzyme activity associated with polyamine metabolism in the rat fetal liver during the perinatal period]

Insights

During rat development, ornithine decarboxylase (ODC) and spermidine/spermine-N1-acetyltransferase (SAT) enzyme activity significantly impacts liver growth. Maintaining putrescine levels is crucial for polyamine metabolism and tissue proliferation.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Molecular Biology

Context:

  • Polyamines are essential for cell growth and proliferation.
  • Enzymes like ornithine decarboxylase (ODC), S-adenosylmethionine decarboxylase (SAMDC), and spermidine/spermine-N1-acetyltransferase (SAT) regulate polyamine metabolism.
  • The perinatal period is a critical window for organ development.

Purpose:

  • To investigate the activity changes of ODC, SAMDC, and SAT in developing rat liver during the perinatal period.
  • To correlate enzyme activity with liver growth rates.

Summary:

  • ODC activity was highest in fetal liver, decreasing significantly with gestation and remaining low neonatally, except for a rise at day 5.
  • SAT activity was high in early fetal development, decreasing to mature levels by day 21 of gestation.
  • SAMDC activity remained relatively high but showed fluctuations, increasing towards mature levels after day 5.
  • A strong positive correlation was observed between ODC activity and liver growth rate (r=0.92) and between SAT activity and liver growth rate (r=0.95).

Impact:

  • The findings highlight the critical role of ODC and SAT in regulating polyamine levels for fetal liver growth.
  • Maintaining adequate putrescine levels via ODC and SAT is suggested to be vital for cellular proliferation and tissue development during fetal stages.
  • This research provides insights into the biochemical regulation of growth during a sensitive developmental period.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...